BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18712106)

  • 1. [Furin and its biological role].
    Kibirev VK; Osadchuk TV; Radavskiĭ IuL
    Ukr Biokhim Zh (1999); 2007; 79(6):5-18. PubMed ID: 18712106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.
    Nakayama K
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):625-35. PubMed ID: 9599222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.
    Basak A; Lazure C
    Biochem J; 2003 Jul; 373(Pt 1):231-9. PubMed ID: 12662153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as substrates for PC1.
    Basak A; Ernst B; Brewer D; Seidah NG; Munzer JS; Lazure C; Lajoie GA
    J Pept Res; 1997 Jun; 49(6):596-603. PubMed ID: 9266488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of proprotein convertases.
    Basak A
    J Mol Med (Berl); 2005 Nov; 83(11):844-55. PubMed ID: 16215768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity.
    Henrich S; Cameron A; Bourenkov GP; Kiefersauer R; Huber R; Lindberg I; Bode W; Than ME
    Nat Struct Biol; 2003 Jul; 10(7):520-6. PubMed ID: 12794637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymic characterization in vitro of recombinant proprotein convertase PC4.
    Basak A; Touré BB; Lazure C; Mbikay M; Chrétien M; Seidah NG
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):29-37. PubMed ID: 10493908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barley serine proteinase inhibitor 2-derived cyclic peptides as potent and selective inhibitors of convertases PC1/3 and furin.
    Villemure M; Fournier A; Gauthier D; Rabah N; Wilkes BC; Lazure C
    Biochemistry; 2003 Aug; 42(32):9659-68. PubMed ID: 12911307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.
    Henrich S; Lindberg I; Bode W; Than ME
    J Mol Biol; 2005 Jan; 345(2):211-27. PubMed ID: 15571716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.
    Tian S; Jianhua W
    Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New non-peptide inhibitors of furin].
    Kibirev VK; Osadchuk TV; Vadziuk OB; Garazd MM
    Ukr Biokhim Zh (1999); 2010; 82(2):15-21. PubMed ID: 20684240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.
    Klimpel KR; Molloy SS; Thomas G; Leppla SH
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10277-81. PubMed ID: 1438214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine.
    Jiao GS; Cregar L; Wang J; Millis SZ; Tang C; O'Malley S; Johnson AT; Sareth S; Larson J; Thomas G
    Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19707-12. PubMed ID: 17179036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of tight binding inhibitors and their action on the proprotein-processing enzyme furin.
    Angliker H
    J Med Chem; 1995 Sep; 38(20):4014-8. PubMed ID: 7562936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structure and properties of proprotein convertase inhibitors].
    Kibirev VK; Osadchuk TV
    Ukr Biokhim Zh (1999); 2012; 84(2):5-29. PubMed ID: 22642118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160.
    Hallenberger S; Bosch V; Angliker H; Shaw E; Klenk HD; Garten W
    Nature; 1992 Nov; 360(6402):358-61. PubMed ID: 1360148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen.
    Molloy SS; Bresnahan PA; Leppla SH; Klimpel KR; Thomas G
    J Biol Chem; 1992 Aug; 267(23):16396-402. PubMed ID: 1644824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral envelope glycoprotein processing: structural investigation of the cleavage site.
    Moulard M; Chaloin L; Canarelli S; Mabrouk K; Darbon H
    Biochemistry; 1998 Mar; 37(13):4510-7. PubMed ID: 9521771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage.
    Bergeron E; Basak A; Decroly E; Seidah NG
    Biochem J; 2003 Jul; 373(Pt 2):475-84. PubMed ID: 12691605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.